Risk factors for pneumonitis in advanced extrapulmonary cancer patients treated with immune checkpoint inhibitors

Abstract Background Immune-mediated pneumonitis has a high mortality rate; however, information regarding the related risk factors remains limited. This study aimed to analyze risk factors for pneumonitis, including smoking and lung metastasis (LM), in patients with extrapulmonary primary tumors. Me...

Description complète

Détails bibliographiques

Auteurs principaux:	Yasuki Uchida, Daisuke Kinose, Yukihiro Nagatani, Sachiko Tanaka-Mizuno, Hiroaki Nakagawa, Kentaro Fukunaga, Masafumi Yamaguchi, Yasutaka Nakano
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2022-05-01
Collection:	BMC Cancer
Sujets:	Extrapulmonary tumor Immune checkpoint inhibitors Lung metastasis Nivolumab Pembrolizumab Pneumonitis
Accès en ligne:	https://doi.org/10.1186/s12885-022-09642-w
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!